MMB MedicalMarketingBerlin GmbH
Successful takeover of INJEX Pharma GmbH, needle free syringe, by MMB Medical Marketing Berlin GmbH / Paketeria AG
MMB MedicalMarketingBerlin GmbH / Key word(s): Enterprise/ 06.09.2011 / 12:00 --------------------------------------------------------------------- Paketeria AG ISIN: DE000A0STYL7 Berlin, 06.09.2011 Successful takeover of INJEX Pharma GmbH, needle free syringe, by MMB Medical Marketing Berlin GmbH / Paketeria AG INJEX Pharma will be merged with Paketeria AG, which just recently announced the withdrawal of insolvency MMB Medical Marketing Berlin GmbH announces the 100 % take over of Injex Pharma GmbH. Injex Pharma owns the worldwide rights to the innovative needle-free injection technology, the full automation assembly production lines and inventory with a value of a few million Euros. (Distributor purchase price). MMB is planning to merge Injex Pharma with Paketeria AG, which announced the withdrawal of insolvency a short time ago. Under the management of Mr. Jim Fukushima, Injex Pharma mainly delivered disposables to existing INJEX users and had no active marketing or sales activities. Marketing and sales were performed successfully by MMB starting at the end of last year, MMB signed several exclusive agreements with distributors from a variety of diverse countries. These exclusive contracts shall be transferred to Paketeria AG as part of the deal. The purchase price of 2.4 Million Euro will be implemented in installments in accordance with the achievement of certain milestones. A first payment was wired before the signatures by MMB. Jim Fukushima and Andy Rösch have been involved and engaged with INJEX for more than 12 years. Directly related to this long relationship, a win/win solution was found and a deal was signed. The assets of Injex Pharma, such as worldwide rights, production lines, tools as well as existing inventory, combined with the revenues and profits from signed and expected new exclusive distributor agreements by MMB has created promising prospects for the future under the roof of Paketeria AG. The purchase contract was signed last Friday, September 2th. The former owner and managing director, Mr. Jim Fukushima stated: 'Andy and I have a long relationship based on the innovative product INJEX. The sale of Injex Pharma to MMB is a huge opportunity for INJEX and the chance for me to concentrate on a project involving a needle-free injection technology with prefilled ampoules. We, Andy and I, will be in close communication about these extra market opportunities.' Andy Rösch stated: 'After the final end of insolvency of Paketeria AG, this is another important milestone for our planned future of Paketeria AG. I want to thank Jim Fukushima, who opened up all the future chances with a very special and unusual purchase agreement. We understand the next tasks and challenges: Merging INJEX in Paketeria AG and the restart of production under the QM regulations of ISO for medical devices and sterile products. ' Contact: Andy Rösch Medical Marketing Berlin GmbH Buckower Damm 114 12349 Berlin Tel.: 030/53096768 andy.roesch@medical-marketing-berlin.com Dr. Ulrich Franz member of the supervisory board Paketeria AG Ulrich.franz@gmx.net End of Media Release --------------------------------------------------------------------- 06.09.2011 Dissemination of a Press Release, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- 138356 06.09.2011
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden